Related Experiment Video
Updated: Oct 25, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
Diabetic dyslipidaemia.
Subashini C Thambiah1, Leslie Charles Lai2
1Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.
Diabetic dyslipidaemia, characterized by abnormal lipid profiles, significantly increases cardiovascular risk. Understanding its mechanisms and management is crucial for preventing atherosclerotic cardiovascular disease in diabetic patients.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus (DM) is a global pandemic and a major risk factor for atherosclerotic cardiovascular disease (ASCVD).
- Diabetic dyslipidaemia, a key contributor to ASCVD in DM, involves quantitative and qualitative lipoprotein alterations.
- Pathophysiological links between DM, dyslipidaemia, and ASCVD are increasingly understood.
Purpose of the Study:
- To review the pathophysiology and management of diabetic dyslipidaemia concerning ASCVD.
- To highlight the impact of diabetic kidney disease on lipid profiles and vice versa.
- To discuss biomarkers and therapeutic strategies for cardiovascular risk reduction in diabetic patients.
Main Methods:
- Literature review of the pathophysiology of diabetic dyslipidaemia.
- Analysis of lipid profile modifications in diabetes.
- Examination of clinical trials on lipid-lowering and non-lipid-lowering therapies.
- Review of international guidelines for lipid management in diabetes.
Main Results:
- Diabetic dyslipidaemia includes hypertriglyceridaemia, low HDL, and altered LDL/VLDL particle characteristics.
- Diabetic kidney disease influences lipid profiles, and lipid changes can contribute to type 2 diabetes.
- Both lipid-lowering and non-lipid-lowering therapies show efficacy in reducing cardiovascular risk.
- International guidelines offer frameworks for tailored lipid management.
Conclusions:
- Understanding diabetic dyslipidaemia mechanisms is vital for developing novel therapeutic strategies.
- Current international guidelines provide a basis for personalized patient management.
- Effective management of diabetic dyslipidaemia is essential for mitigating ASCVD risk in diabetic populations.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Diabetes: Symptoms, Diagnosis, and Complications
Lipids: Dietary Sources and Requirements

